CellScape Alternatives & Competitors
8 companies similar to CellScape — Bringing accessible, non-invasive prenatal genetic testing to every woman throug...
Companies similar to CellScape
BillionToOne
We push the boundaries of molecular diagnostics through quantitative technologies.
Parabase Genomics
Pioneering the future of newborn genetic diagnostics with rapid, comprehensive testing for...
Testmate Health
Testmate is pioneering the next generation of low-cost tests, starting with sexual health...
Rival Readout
Competing with CellScape? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
GENZ Biotechnology
Developing novel IVD solutions
Vixiar Medical
Developing non-invasive devices and systems for monitoring cardiopulmonary diseases.
ENDRA Life Sciences (Nasdaq: NDRA)
Focused on early detection of liver disease
About CellScape
CellScape is a biotech startup focused on revolutionizing prenatal genetic testing with their pioneering whole fetal cell technology. The company, formerly known as Saryna Medical Corp, is situated in the thriving biotech hub of Newark, California. Founded in 2008, CellScape's primary mission is to make comprehensive p...
Prenatal Genetic Testing, Whole Fetal Cell Technology, Non-invasive Testing, Biotech Innovation, Molecular Diagnostics, Blood Test Technology, Women's Healthcare, Startup, Biotech Hub, San Francisco Bay Area, Innovative Healthcare, Genetic Testing, Cost-effective Diagnostics, Fetal Health
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around CellScape: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at CellScape on 12 Sep 2024. The 8 companies listed here were last checked between 12 Sep 2024 and 7 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.